Atrás
67
Rango del Día
$17.01
$17.77
Rango de 52 Semanas
$11.63
$23.87
Volumen
2,293,661
Promedio 50D / 200D
$20.42
/
$17.32
Cierre Anterior
$17.51
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4915.5 | 0.3 |
| P/B | 19.9 | 2.9 |
| ROE % | -0.5 | 3.7 |
| Net Margin % | 0.0 | 3.8 |
| Rev Growth 5Y % | 35.6 | 10.0 |
| D/E | 1.9 | 0.2 |
Precio Objetivo de Analistas
Hold
$24.50
+40.6%
Low: $18.00
High: $30.00
P/E Futuro
133.2
EPS Futuro
$0.13
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
5.2 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.71
$1.64 – $1.80
|
14 B | 1 |
| FY2029 |
$1.29
$1.24 – $1.36
|
11 B | 1 |
| FY2028 |
$0.73
$0.52 – $0.86
|
8 B | 5 |
Puntos Clave
Revenue grew 35.60% annually over 5 years — strong growth
Generating 113.15M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.46%
Capital efficient — spends only 0.68% of revenue on capex
ROIC of 2.14% — low return on invested capital
Interest coverage of 0.93× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
35.60%
Revenue (1Y)46.06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-0.52%
ROIC2.14%
Net Margin-0.02%
Op. Margin0.37%
Seguridad
Debt / Equity
1.89
Current Ratio1.74
Interest Coverage0.93
Valoración
P/E Ratio
-4915.53
P/B Ratio19.85
EV/EBITDA224.98
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 46.06% | Revenue Growth (3Y) | 47.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 35.60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.95B | Net Income (TTM) | -724,000.0 |
| ROE | -0.52% | ROA | -0.07% |
| Gross Margin | 12.37% | Operating Margin | 0.37% |
| Net Margin | -0.02% | Free Cash Flow (TTM) | 113.15M |
| ROIC | 2.14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.89 | Current Ratio | 1.74 |
| Interest Coverage | 0.93 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4915.53 | P/B Ratio | 19.85 |
| P/S Ratio | 0.90 | PEG Ratio | 54.31 |
| EV/EBITDA | 224.98 | Dividend Yield | 0.00% |
| Market Cap | 3.56B | Enterprise Value | 3.32B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.95B | 2.70B | 1.82B | 1.43B | 1.17B |
| Net Income | -724,000.0 | -128.04M | -148.02M | -149.55M | -195.29M |
| EPS (Diluted) | 0.00 | -0.67 | -0.79 | -0.83 | -1.14 |
| Gross Profit | 488.56M | 296.69M | 201.03M | 184.28M | 128.73M |
| Operating Income | 14.75M | -101.56M | -127.82M | -128.64M | -178.07M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.07B | 782.06M | 591.88M | 633.86M | 630.90M |
| Total Liabilities | 886.51M | 681.11M | 433.81M | 394.56M | 324.84M |
| Shareholders' Equity | 179.28M | 99.85M | 156.95M | 238.13M | 306.04M |
| Total Debt | 338.07M | 329.26M | 170.79M | 164.60M | 157.60M |
| Cash & Equivalents | 577.94M | 432.86M | 202.90M | 409.55M | 466.60M |
| Current Assets | 831.14M | 661.64M | 483.54M | 544.55M | 552.86M |
| Current Liabilities | 476.53M | 351.85M | 263.02M | 229.96M | 167.25M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#87 of 618
Actividad Reciente
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026